-
VRPX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
Virpax Pharmaceuticals (VRPX)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.51 mm | 1.51 mm | 1.51 mm | 1.51 mm | 1.51 mm | 1.51 mm |
Cash burn (monthly) | (no burn) | 635.70 k | 1.13 mm | 1.01 mm | 956.90 k | 1.39 mm |
Cash used (since last report) | n/a | 1.40 mm | 2.49 mm | 2.21 mm | 2.10 mm | 3.06 mm |
Cash remaining | n/a | 116.26 k | -973.30 k | -698.83 k | -589.48 k | -1.55 mm |
Runway (months of cash) | n/a | 0.2 | -0.9 | -0.7 | -0.6 | -1.1 |
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 0 |
Closed positions | 2 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 289.00 k |
Total shares | 2.84 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Anthony P. Mack | 2.73 mm | $0.00 |
Intracoastal Capital | 110.73 k | $254.00 k |
Signature Resources Capital Management | 50.00 | $35.00 k |
Proequities | 0.00 | $0.00 |